There will be 12 Satellite Symposia, each focused on separate topics.
| 14:00-15:30 | Protecting Osteoporosis Patients With Bisphosphonates: Examining Sustained Fracture Efficacy |
| Satellite Symposium presented by ROCHE-GSK Chaired by S. ADAMI |
|
| Introduction S. ADAMI |
|
| Sustained efficacy with oral anti-osteoporotic therapies: Reviewing the evidence S. ADAMI |
|
| Translating bone quality and strength to fracture efficacy with bisphosphonates H.K. GENANT |
|
| Application of ibandronate studies to clinical practice S. EPSTEIN |
|
| Q&A / Meeting close S. ADAMI & M.L. BRANDI |
| 16:00-17:30 | Sharing Insights on Musculoskeletal Health |
| Satellite Symposium presented by MSD Chaired by S. ADAMI |
|
| Welcome and opening remarks | |
| Vitamin D and musculoskeletal health S. FERRARI |
|
| Clinical considerations with bisphosphonates: Current issues I. REID |
|
| Bone remodelling effects of current and future therapies R. CHAPURLAT |
|
| Q & A / Panel Discussion |
| 16:00-17:30 | Plant-based Nutrition and Bone Health |
| Satellite Symposium presented by ALPRO FOUNDATION Chaired by R. RIZZOLI |
|
| The impact of nutrition on bone health J.Y. REGINSTER |
|
| Importance of nutrition for optimal bone development during childhood and adolescence J.P. BONJOUR |
|
| Nutritional association with bone loss during the menopausal transition B. DAWSON-HUGHES |
|
| Are soyfoods useful for optimal bone health? A. LANOU |
|
| Do vegetarians have a normal bone mass? S. LANHAM-NEW |
| 12:15-13:45 | Superior Antifracture Efficacy From Improved Bone Quality |
| Lunch Satellite Symposium presented by SERVIER Chaired by M.L. BRANDI & J.Y. REGINSTER |
|
| Introduction M.L. BRANDI |
|
| Assessment of bone quality: Methods and implications for treatment D. FELSENBERG |
|
| Improvement in bone microstructure: An achievable target R. RIZZOLI |
|
| Strontium ranelate: Clinical proof of superior antifracture efficacy B. CORTET |
|
| Patient benefits with strontium ranelate – Analysis of clinical cases M.L. BRANDI |
|
| Conclusion J.Y. REGINSTER |
| 12:15-13:45 Hall B |
Optimising Patient Care in Osteoporotic Vertebral Compression Fractures: The Role of Minimally Invasive Therapies |
| Lunch Satellite Symposium presented by MEDTRONIC Chaired by J.A. KANIS |
|
| Welcome & Introduction J.A. KANIS |
|
| Orthopaedic management of vertebral compression fractures D. MARSH |
|
| Recent clinical evidence in treating vertebral compression fractures: Should we change our beliefs? C. MÜLLER |
|
| Cost-effectiveness of minimally invasive interventions for vertebral compression fractures C. COOPER |
|
| How do different treatments for vertebral fractures have an impact on the mortality of patients? A. EDIDIN |
|
| Closing remarks J.A. KANIS |
| 18:15-19:45 | Zoledronic Acid 5 mg – Optimizing Fracture Protection in Osteoporosis Treatment |
| Satellite Symposium presented by NOVARTIS Chaired by S. ADAMI & J.Y. REGINSTER |
|
| Welcome & introduction S. ADAMI |
|
| The material and structural basis of bone fragility: Insights into the antifracture efficacy of zoledronic acid E. SEEMAN |
|
| Osteoporosis management across the patient spectrum S.E. PAPAPOULOS |
|
| Optimizing fracture protection in osteoporosis treatment – Panel discussion ALL FACULTY |
|
| Closing remarks J.Y. REGINSTER |
| 18:15-19:45 | Strategies and Tactics For the Management of Severe Osteoporosis |
| Satellite Symposium presented by ELI LILLY Chaired by D. AGNUSDEI & A.GIUSTINA |
|
| Bone quality: From images to bone strength measures C. GLUER |
|
| Teriparatide: From bone cracker to bone builder J. STEPAN |
|
| Teriparatide treatment of GIOP: 24 months results H. DOBNIG |
| 12:15-13:45 | The Long Road Towards Disease Modification in Osteoarthritis: Current Perspectives |
| Lunch Satellite Symposium presented by ROTTAPHARM / MADAUS Chaired by C.M. MONTECUCCO |
|
| Opening remarks C.M. MONTECUCCO |
|
| Pharmacokinetic and pharmacodynamic considerations on the clinical use of glucosamine in osteoarthritis R.D. ALTMAN |
|
| Structure-modifying studies of glucosamine in osteoarthritis: The problem, the data and future perspsectives M.C. HOCHBERG |
|
| Interpreting the current evidence on glucoamine sulphate effects as a symptom-modifying drug in knee osteoarthritis J.Y. REGINSTER |
|
| Closing remarks C.M. MONTECUCCO |
| 12:15-13:45 Hall B |
Challenges and Advances in the Treatment of Osteoporosis |
| Lunch Satellite Symposium presented by AMGEN in collaboration with GSK Co-Chaired by M.L. BRANDI & R. RIZZOLI |
|
| Cost of fractures: The burden and cost of osteoporosis-related fractures J.A. KANIS |
|
| Bone’s structural properties: impact of RANK Ligand inhibition E. SEEMAN |
|
| New clinical evidence for RANK Ligand inhibition in osteoporosis S.E. PAPAPOULOS |
| 18:15-19:45 | How, When and Why: Different Approaches For a Common Disease |
| Satellite Symposium presented by IBSA-GENEVRIER Chaired by J.Y REGINSTER |
|
| Welcome & introduction | |
| Different strategies for the management of knee osteoarthritis: Oral versus intra-articular therapy D. UEBELHART |
|
| Efficacy evaluation of a new intra-articular hyaluronic acid for symptomatic knee OA K. PAVELKA |
|
| Chondroitin sulphate vs. NSAIDS: A budget impact analysis R. TARRICONE |
|
| Discussion & conclusion |
| 18:15-19:45 | Osteoporosis Management: What Have We Learned From the Past Decade? |
| Satellite Symposium presented by SANOFI-AVENTIS / WARNER CHILCOTT Chaired by M.L. BRANDI & S. FERRARI |
|
| Management of fractures and international comparison of treatment patterns for women at risk of fracture: The Global Longitudinal study of Osteoporosis in Women (GLOW) S. ADAMI |
|
| Safety of bisphosphonates in the treatments of osteoporosis S.E. PAPAPOULOS |
|
| A decade of experience in osteoporosis management with risedronate S. BOONEN |
|
| Longitudinal change in clinical fracture incidence in daily practice: An innovative methodology S. FERRARI. |
|
| Conclusion M.L. BRANDI |
| 12:30-14:00 | Nutrition, Physical Activity and Bone Health: State of the Art and Emerging Trends |
| Lunch Satellite Symposium presented by DANONE RESEARCH Chaired by M.L. BIANCHI & R. RIZZOLI |
|
| Nutrients, muscle and bone: Where do we stand? H.A. BISCHOFF-FERRARI |
|
| Dairy products and bone health: Devil or angels? R. RIZZOLI |
|
| Interaction between nutrients and exercise on bone R. DALY |